Order Article Reprints

Saddik MS, Elsayed MMA, Abdel-Rheem AA, El-Mokhtar MA, Mosa ES, Al-Hakkani MF, Al-Shelkamy SA, Khames A, Daha MA, Abdel-Aleem JA. A Novel C@Fe@Cu Nanocomposite Loaded with Doxorubicin Tailored for the Treatment of Hepatocellular Carcinoma. Pharmaceutics. 2022; 14(9):1845. https://doi.org/10.3390/pharmaceutics14091845

Saddik, Mohammed S., Mahmoud M. A. Elsayed, Amany A. Abdel-Rheem, Mohamed A. El-Mokhtar, Eisa S. Mosa, Mostafa F. Al-Hakkani, Samah A. Al-Shelkamy, Ali Khames, Mohamed A. Daha, and Jelan A. Abdel-Aleem. 2022. "A Novel C@Fe@Cu Nanocomposite Loaded with Doxorubicin Tailored for the Treatment of Hepatocellular Carcinoma" Pharmaceutics 14, no. 9: 1845. https://doi.org/10.3390/pharmaceutics14091845

Saddik, M. S., Elsayed, M. M. A., Abdel-Rheem, A. A., El-Mokhtar, M. A., Mosa, E. S., Al-Hakkani, M. F., Al-Shelkamy, S. A., Khames, A., Daha, M. A., & Abdel-Aleem, J. A. (2022). A Novel C@Fe@Cu Nanocomposite Loaded with Doxorubicin Tailored for the Treatment of Hepatocellular Carcinoma. Pharmaceutics, 14(9), 1845. https://doi.org/10.3390/pharmaceutics14091845